Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2004

01.02.2004 | Clinical Investigation

Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies

verfasst von: Dirk Marquardt, Wolfgang E. Lieb, Franz Grehn

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the long-term outcome of trabeculectomy under the conditions of intensified postoperative care (IPC) compared with conventional follow-up.

Methods

One hundred and seventy-seven consecutive primary trabeculectomies (168 patients) with a median follow-up of 4.5 years were retrospectively analyzed at the University Eye Hospital, Würzburg. Seventy-three trabeculectomies (70 patients) were followed by the surgeon under the conditions of IPC (group 1), and 104 trabeculectomies (98 patients) were followed by other ophthalmologists without IPC (group 2). The following measures to control wound healing were predominantly used in group 1: (1) increase in topical steroid administration if corkscrew vessels were present; (2) repeated injections of 5-fluorouracil (5-FU) at the beginning of bleb scarring; and/or (3) needling plus 5-FU administration if an encapsulated bleb developed. Postoperative intraocular pressure (IOP) was defined as “successful” when it did not exceed 21 mmHg and was at least 20% lower than the treated preoperative IOP. Stable visual acuity was defined as ±1 line.

Results

The success rates of IOP control were about 95% in both groups. In the IPC group 45 of 73 eyes fulfilled all success criteria without additional anti-glaucoma medication (61.6%), whereas in conventional follow-up only 33 of 104 eyes fulfilled all success criteria without medication (31.7%).

Conclusions

This study demonstrates that a much higher proportion of filtering blebs reach target IOP without medication if measures of IPC are consistently used by a glaucoma specialist when necessary.
Literatur
1.
Zurück zum Zitat Adelman RA, Brauner SC, Afshari NA, Grosskreutz CL (2003) Cataract formation after initial trabeculectomy in young patients. Ophthalmology 110:625–629CrossRefPubMed Adelman RA, Brauner SC, Afshari NA, Grosskreutz CL (2003) Cataract formation after initial trabeculectomy in young patients. Ophthalmology 110:625–629CrossRefPubMed
2.
Zurück zum Zitat Araujo SV, Spaeth GL, Roth SM, Starita RJ (1995) A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 102:1753–1759CrossRefPubMed Araujo SV, Spaeth GL, Roth SM, Starita RJ (1995) A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 102:1753–1759CrossRefPubMed
3.
Zurück zum Zitat Ball SF, Vinh T, Gebhardt BM (1987) Biphasic effect of corticosteroids on protein and DANN synthesis by human subconjunctival fibroblasts in culture. Invest Ophthalmol Vis Sci 258:378 Ball SF, Vinh T, Gebhardt BM (1987) Biphasic effect of corticosteroids on protein and DANN synthesis by human subconjunctival fibroblasts in culture. Invest Ophthalmol Vis Sci 258:378
4.
Zurück zum Zitat Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563CrossRefPubMed Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563CrossRefPubMed
5.
Zurück zum Zitat Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL (1991) Conjunctival impression cytology in patients with glaucoma using ling-term topical medication. Am J Ophthalmol 112:297–301CrossRefPubMed Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL (1991) Conjunctival impression cytology in patients with glaucoma using ling-term topical medication. Am J Ophthalmol 112:297–301CrossRefPubMed
6.
Zurück zum Zitat Breslin RJ, Wasserkrug HL, Efron G, Barbul A (1988) Suppressor cell generation during normal wound healing. J Surg Res 44:321–325CrossRefPubMed Breslin RJ, Wasserkrug HL, Efron G, Barbul A (1988) Suppressor cell generation during normal wound healing. J Surg Res 44:321–325CrossRefPubMed
7.
Zurück zum Zitat Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10:237–249CrossRefPubMed Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10:237–249CrossRefPubMed
8.
Zurück zum Zitat Broadway DC, Grierson I, O’Brien C, Hitchings RA (1994) Adverse effect of topical anti-glaucomatous medication regimes. II. Effects on the outcome of filtration surgery. Arch Ophthalmol 112:1446–1454CrossRefPubMed Broadway DC, Grierson I, O’Brien C, Hitchings RA (1994) Adverse effect of topical anti-glaucomatous medication regimes. II. Effects on the outcome of filtration surgery. Arch Ophthalmol 112:1446–1454CrossRefPubMed
9.
Zurück zum Zitat Cairns JE (1968) Trabeculectomy: preliminary report on a new method. Am J Ophthalmol 66:673–679CrossRefPubMed Cairns JE (1968) Trabeculectomy: preliminary report on a new method. Am J Ophthalmol 66:673–679CrossRefPubMed
10.
Zurück zum Zitat Chaudhry IA, Pasha MA, O’Connor DJ, Weitzman ML, Caprioli J (2000) Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am J Ophthalmol 130:700–703CrossRefPubMed Chaudhry IA, Pasha MA, O’Connor DJ, Weitzman ML, Caprioli J (2000) Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am J Ophthalmol 130:700–703CrossRefPubMed
11.
Zurück zum Zitat Chen TC, Wilensky JT, Viana MA (1997) Long-term follow-up of initially successful trabeculectomy. Ophthalmology 104:1120–1125CrossRefPubMed Chen TC, Wilensky JT, Viana MA (1997) Long-term follow-up of initially successful trabeculectomy. Ophthalmology 104:1120–1125CrossRefPubMed
12.
Zurück zum Zitat Cordeiro MF, Gay JA, Khaw PT (1999) Human anti-transforming growth factor-beta 2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 40:2225–2234PubMed Cordeiro MF, Gay JA, Khaw PT (1999) Human anti-transforming growth factor-beta 2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 40:2225–2234PubMed
13.
Zurück zum Zitat Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B (1993) Loss of visual acuity after trabeculectomy. Ophthalmology 100:599–612CrossRefPubMed Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B (1993) Loss of visual acuity after trabeculectomy. Ophthalmology 100:599–612CrossRefPubMed
14.
Zurück zum Zitat Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT (1998) Antimetabolite-induced apoptosis in Tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci 39:449–454PubMed Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT (1998) Antimetabolite-induced apoptosis in Tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci 39:449–454PubMed
15.
Zurück zum Zitat Cupps TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133–155CrossRefPubMed Cupps TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133–155CrossRefPubMed
16.
Zurück zum Zitat D’Ermo F, Bonomi L, Doro D (1979) A critical analyis of the long-term results of trabeculectomy. Am J Ophthalmol 88:829–835CrossRefPubMed D’Ermo F, Bonomi L, Doro D (1979) A critical analyis of the long-term results of trabeculectomy. Am J Ophthalmol 88:829–835CrossRefPubMed
17.
Zurück zum Zitat Diestelhorst M, Khalili MA, Krieglstein GK (1998–9) Trabeculectomy: a retrospective follow-up of 700 eyes. Int Ophthalmol 22:211–222CrossRefPubMed Diestelhorst M, Khalili MA, Krieglstein GK (1998–9) Trabeculectomy: a retrospective follow-up of 700 eyes. Int Ophthalmol 22:211–222CrossRefPubMed
19.
Zurück zum Zitat Grehn F (1997) Aktuelle Aspekte filtrierender Operationen bei primärem Offenwinkelglaukom. In: Krieglstein GK (ed) Glaukom. Kaden, Heidelberg, pp 56–59 Grehn F (1997) Aktuelle Aspekte filtrierender Operationen bei primärem Offenwinkelglaukom. In: Krieglstein GK (ed) Glaukom. Kaden, Heidelberg, pp 56–59
20.
Zurück zum Zitat Hattenhauer MG, Johnson DH, Ing HH, Hodge DO, Butterfield LC, Herman DC, Gray DT (1999) Probability of filtration surgery in patients with open-angle glaucoma. Arch Ophthalmol 128:301–309 Hattenhauer MG, Johnson DH, Ing HH, Hodge DO, Butterfield LC, Herman DC, Gray DT (1999) Probability of filtration surgery in patients with open-angle glaucoma. Arch Ophthalmol 128:301–309
21.
Zurück zum Zitat Hitchings RA (1998) Efficacy of glaucoma treatment: the role of trabeculectomy. In: Jönsson B, Krieglstein G, eds. Primary open-angle glaucoma—differences in international treatment patterns and costs. ISIS Medical Media, Oxford, pp 154–162 Hitchings RA (1998) Efficacy of glaucoma treatment: the role of trabeculectomy. In: Jönsson B, Krieglstein G, eds. Primary open-angle glaucoma—differences in international treatment patterns and costs. ISIS Medical Media, Oxford, pp 154–162
22.
Zurück zum Zitat Hitchings RA, Migdal CS, Wormald R, Poinooswamy D, Fitzke F (1994) The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye 8:117–120CrossRefPubMed Hitchings RA, Migdal CS, Wormald R, Poinooswamy D, Fitzke F (1994) The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye 8:117–120CrossRefPubMed
23.
Zurück zum Zitat Khaw PT, Siriwardena D (1999) Glaucoma surgery in the United Kingdom: why, who and when. Eye 13:493–494CrossRefPubMed Khaw PT, Siriwardena D (1999) Glaucoma surgery in the United Kingdom: why, who and when. Eye 13:493–494CrossRefPubMed
24.
Zurück zum Zitat Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G (1992) Five-minute treatment with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 110:1150–1154CrossRefPubMed Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G (1992) Five-minute treatment with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 110:1150–1154CrossRefPubMed
25.
Zurück zum Zitat Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS (1992) The long-term effect of 5-fluorouracil and sodium butyrate on human Tenon’s fibroblasts. Invest Ophthalmol Vis Sci 33:2043–2052PubMed Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS (1992) The long-term effect of 5-fluorouracil and sodium butyrate on human Tenon’s fibroblasts. Invest Ophthalmol Vis Sci 33:2043–2052PubMed
26.
Zurück zum Zitat Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF (2001) Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol 12:143–148CrossRefPubMed Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF (2001) Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol 12:143–148CrossRefPubMed
27.
Zurück zum Zitat Koryllos K (1967) Trabeculectomy: a new glaucoma operation. Bull Soc Hell Ophthalmol 35:147–157 Koryllos K (1967) Trabeculectomy: a new glaucoma operation. Bull Soc Hell Ophthalmol 35:147–157
28.
Zurück zum Zitat Lavin MJ, Wormald RP, Migdal CS, Hitchings RA (1990) The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 108:1543–1548CrossRefPubMed Lavin MJ, Wormald RP, Migdal CS, Hitchings RA (1990) The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 108:1543–1548CrossRefPubMed
29.
Zurück zum Zitat Leyland M, Bloom P, Zinicola E, McAlister J, Rassam S, Migdal C (2001) Single intraoperative application of 5-Fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial. J Glaucoma 10:452–457CrossRefPubMed Leyland M, Bloom P, Zinicola E, McAlister J, Rassam S, Migdal C (2001) Single intraoperative application of 5-Fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial. J Glaucoma 10:452–457CrossRefPubMed
30.
Zurück zum Zitat Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP; CIGTS Study Group (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953CrossRefPubMed Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP; CIGTS Study Group (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953CrossRefPubMed
31.
Zurück zum Zitat Migdal C, Gregory W, Hitchings RA (1994) Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 101:1651–1656CrossRefPubMed Migdal C, Gregory W, Hitchings RA (1994) Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 101:1651–1656CrossRefPubMed
33.
Zurück zum Zitat Mutsch YA, Grehn F (2000) Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC). Graefes Arch Clin Exp Ophthalmol 238:884–891CrossRefPubMed Mutsch YA, Grehn F (2000) Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC). Graefes Arch Clin Exp Ophthalmol 238:884–891CrossRefPubMed
34.
Zurück zum Zitat Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J (1995) Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 102:1760–1769CrossRefPubMed Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J (1995) Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 102:1760–1769CrossRefPubMed
35.
Zurück zum Zitat Occleston NL, Daniels JT, Tarnuzzer RW, Sethi KK, Alexander RA, Bhattacharya SS, Schultz GS, Khaw PT (1997) Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behaviour. Invest Ophthalmol Vis Sci 38:1998–2007PubMed Occleston NL, Daniels JT, Tarnuzzer RW, Sethi KK, Alexander RA, Bhattacharya SS, Schultz GS, Khaw PT (1997) Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behaviour. Invest Ophthalmol Vis Sci 38:1998–2007PubMed
36.
Zurück zum Zitat Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M, Johnson DH (2002) Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133:764–772CrossRefPubMed Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M, Johnson DH (2002) Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133:764–772CrossRefPubMed
37.
Zurück zum Zitat Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO (2001) The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 132:27–35CrossRefPubMed Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO (2001) The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 132:27–35CrossRefPubMed
38.
Zurück zum Zitat Picht G, Grehn F (1998) Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 9:2–8CrossRefPubMed Picht G, Grehn F (1998) Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 9:2–8CrossRefPubMed
39.
Zurück zum Zitat Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation of filtering bleb developement. Graefes Arch Clin Exp Ophthalmol 239:199–207CrossRefPubMed Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation of filtering bleb developement. Graefes Arch Clin Exp Ophthalmol 239:199–207CrossRefPubMed
40.
Zurück zum Zitat Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, O’Connor T, Brill I (1988) The development of encapsulated filtering blebs. Ophthalmology 95:1163–1168CrossRefPubMed Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, O’Connor T, Brill I (1988) The development of encapsulated filtering blebs. Ophthalmology 95:1163–1168CrossRefPubMed
41.
Zurück zum Zitat Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM (1992) Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medication. Ophthalmology 99:197–202CrossRefPubMed Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM (1992) Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medication. Ophthalmology 99:197–202CrossRefPubMed
42.
Zurück zum Zitat Seetner A, Morin DJ (1979) Healing of trabeculectomies in rabbits. Can J Ophthalmol 14:121–125PubMed Seetner A, Morin DJ (1979) Healing of trabeculectomies in rabbits. Can J Ophthalmol 14:121–125PubMed
43.
Zurück zum Zitat Serguhn S, Spiegel D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Peudoexfoliationsglaukom und primär chronischen Offenwinkelglaukom. Klin Monatsbl Augenheilkd 215:281–286CrossRefPubMed Serguhn S, Spiegel D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Peudoexfoliationsglaukom und primär chronischen Offenwinkelglaukom. Klin Monatsbl Augenheilkd 215:281–286CrossRefPubMed
44.
Zurück zum Zitat Sherwood MB, Grierson I, Millar L, Hitchings RA (1989) Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients. Ophthalmology 96:327–335CrossRefPubMed Sherwood MB, Grierson I, Millar L, Hitchings RA (1989) Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients. Ophthalmology 96:327–335CrossRefPubMed
45.
Zurück zum Zitat Shingleton BJ (1996) Management of the failing glaucoma filter. Ophthalmic Surg Lasers 27:445–451PubMed Shingleton BJ (1996) Management of the failing glaucoma filter. Ophthalmic Surg Lasers 27:445–451PubMed
46.
Zurück zum Zitat Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal C, Cordeiro MF (2002) Human antitransforming growth factor beta(2) monoclonal antibody—a new modulator of wound healing in trabeculectomy. A randomized placebo controlled clinical study. Ophthalmology 109:427–431CrossRefPubMed Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal C, Cordeiro MF (2002) Human antitransforming growth factor beta(2) monoclonal antibody—a new modulator of wound healing in trabeculectomy. A randomized placebo controlled clinical study. Ophthalmology 109:427–431CrossRefPubMed
47.
Zurück zum Zitat Spaeth GL, Mutlukan E (2001) The use of antimetabolites with trabeculectomy: a critical appraisal. J Glaucoma 10:145–51CrossRefPubMed Spaeth GL, Mutlukan E (2001) The use of antimetabolites with trabeculectomy: a critical appraisal. J Glaucoma 10:145–51CrossRefPubMed
48.
Zurück zum Zitat The AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440CrossRef The AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440CrossRef
49.
Zurück zum Zitat The AGIS Investigators (2001) The Advanced Glaucoma Intervention Study (AGIS). 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 119:1771–9CrossRef The AGIS Investigators (2001) The Advanced Glaucoma Intervention Study (AGIS). 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 119:1771–9CrossRef
50.
Zurück zum Zitat The AGIS Investigators (2002) The Advanced Glaucoma Intervention Study (AGIS). 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 134:481–98CrossRef The AGIS Investigators (2002) The Advanced Glaucoma Intervention Study (AGIS). 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 134:481–98CrossRef
51.
Zurück zum Zitat The Fluorouracil Filtering Surgery Study Group (1996) Five-year follow-up of the Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol 121:349–366CrossRef The Fluorouracil Filtering Surgery Study Group (1996) Five-year follow-up of the Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol 121:349–366CrossRef
52.
Zurück zum Zitat Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull WHO 1:115–121 Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull WHO 1:115–121
53.
Zurück zum Zitat Van Story-Lewis PE, Tenenbaum HC (1986) Glucocorticoid inhibition of fibroblast concentration of collagen gels. Biochem Pharmacol 35:1283–1286CrossRef Van Story-Lewis PE, Tenenbaum HC (1986) Glucocorticoid inhibition of fibroblast concentration of collagen gels. Biochem Pharmacol 35:1283–1286CrossRef
54.
Zurück zum Zitat Vesti E (1993) Development of cataract after trabeculectomy. Acta Ophthalmol (Copenh) 71:777–781 Vesti E (1993) Development of cataract after trabeculectomy. Acta Ophthalmol (Copenh) 71:777–781
55.
Zurück zum Zitat Wada Y, Nakatsu A, Kondo T (1994) Long-term results of trabeculotomy ab externo. Ophthalmic Surg 25:317–320PubMed Wada Y, Nakatsu A, Kondo T (1994) Long-term results of trabeculotomy ab externo. Ophthalmic Surg 25:317–320PubMed
56.
Zurück zum Zitat Watson PG, Grierson I (1981) The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 88:175–196CrossRefPubMed Watson PG, Grierson I (1981) The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 88:175–196CrossRefPubMed
57.
Zurück zum Zitat Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT (1990)The complications of trabeculectomy (a 20-years follow-up). Eye 4:425–438CrossRefPubMed Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT (1990)The complications of trabeculectomy (a 20-years follow-up). Eye 4:425–438CrossRefPubMed
58.
Zurück zum Zitat Weinreb RN (1987) Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology 94:564–570CrossRefPubMed Weinreb RN (1987) Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology 94:564–570CrossRefPubMed
60.
Zurück zum Zitat Wimmer I, Picht G, Grehn F (2002) Influence of previous argon laser trabeculoplasty on transforming growth factor beta-2 concentration in the aqueous humor and bleb scarring following trabeculectomy in POAG and PEX glaucoma. ARVO; B328-GL Wimmer I, Picht G, Grehn F (2002) Influence of previous argon laser trabeculoplasty on transforming growth factor beta-2 concentration in the aqueous humor and bleb scarring following trabeculectomy in POAG and PEX glaucoma. ARVO; B328-GL
61.
Zurück zum Zitat Zeyen T, Miglior S, Pfeiffer N, Cunha-Vaz J, Adamsons I (2003) Reproducibility of evaluation of optic disc change for glaucoma with stereo optic disc photographs. Ophthalmology 110:340–344CrossRefPubMed Zeyen T, Miglior S, Pfeiffer N, Cunha-Vaz J, Adamsons I (2003) Reproducibility of evaluation of optic disc change for glaucoma with stereo optic disc photographs. Ophthalmology 110:340–344CrossRefPubMed
Metadaten
Titel
Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies
verfasst von
Dirk Marquardt
Wolfgang E. Lieb
Franz Grehn
Publikationsdatum
01.02.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2004
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-003-0775-9

Weitere Artikel der Ausgabe 2/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2004 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.